Embera NeuroTherapeutics Competitors and Similar CompaniesClear all

Embera NeuroTherapeutics's competitors and similar companies include Aeglea, UCB, Cipla and EMS Pharma.

	Embera NeuroTherapeutics Embera NeuroTherapeutics is a pharmaceutical company developing treatments for addiction.	Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.	EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.
Founding Date	Founding Date 2005	Founding Date 2013	Founding Date 1928	Founding Date 1935	Founding Date 1964
Type	Type Private	Type Public	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations HQ	Locations Austin, US HQ	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more	Locations BR HQ
Employees	Employees 2	Employees 65117% increase	Employees 9,052	Employees 27,764	Employees 12,7441% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 48.6 m	Valuation ($) 34.3 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) €7.4b (FY, 2025)	Revenue (est.) ₹277.1b (FY, 2026)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods €1.4b (FY, 2025)	Cost of goods ₹95.5b (FY, 2026)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit €7.2b (FY, 2025)	Gross profit ₹195b (FY, 2026)	Gross profit N/A
Net income	Net income N/A	Net income ($155.2m) (FY, 2025)	Net income €1.6b (FY, 2025)	Net income ₹38.7b (FY, 2026)	Net income N/A